Catalysts for Insignis Therapeutics Inc
4 tracked
Apr 30, 2026
phase 1 completion
Insignis Therapeutics Inc — HLK-0006 (Phase I Trial Completion)
HLK-0006
→
Mar 24, 2026
device pma
Intrinsic Therapeutics — Barricaid® Annular Closure Device (PMA supplement)
Insignis Therapeutics Inc
→
Dec 18, 2025
device pma
Intrinsic Therapeutics — Barricaid® Annular Closure Device (PMA supplement)
Insignis Therapeutics Inc
→
Oct 9, 2025
device pma
Intrinsic Therapeutics — Barricaid® Annular Closure Device (PMA supplement)
Insignis Therapeutics Inc
→